Feature | Cath Lab | September 14, 2016

VIVA Announces Late-Breaking Clinical Trial Presentations

VIVA 2016, late breaking trials, cath lab

Vascular Interventional Advances (VIVA) 2016 released its list late-breaking research presentations in vascular interventions. All trials represent data never before presented and are of global significance to physicians and others interested in the rapid advancement of therapies for vascular diseases. The meeting is Sept. 18-22, in Las Vegas, Nev.

Presentations Monday, Sept. 19 

8:31 AM — MOBILE Clinical Trial: MarrOwStim PAD Kit for the Treatment of Critical Limb Ischemia (CLI) in Subjects with Severe Peripheral Arterial Disease (PAD) — Michael P. Murphy, M.D., FACS

8:43 AM — Safety and Performance of the Shockwave Lithoplasty System in Treating Calcified Peripheral Vascular Lesions: Six-Month Results from the Two-phase DISRUPT PAD Study — Thomas Zeller, M.D.

8:55 AM — Results from the IN.PACT SFA Randomized Trial — Prakash Krishnan, M.D.

9:07 AM — VIRTUS US Iliofemoral Stenting IDE Trial  — Stephen Black, M.D.

9:19 AM — Drug-Coated Balloon Treatment for Patients With Intermittent Claudication: Insights from the IN.PACT Global Full Clinical Cohort — Michael R. Jaff, D.O.   

 

Presentations Tuesday, Sept. 20 

8:10 AM — Endovascular Repair in Acute, Complicated Type B Aortic Dissection: 3-Year Results from the Valiant US-IDE Study — Ali Azizzadeh, M.D.  

8:22 AM — Fast-Track Endovascular Aortic Repair: Final Results from the Prospective LIFE Registry — Zvonimir Krajcer, M.D.      

8:34 AM — Arteriovenous Fistula (AVF) Post-Creation Interventions: a Comparison Between Traditional Surgical AVF Creation and a New Endovascular Approach — Charmaine Lok, M.D., FRCPC        

8:46 AM — MAJESTIC 2 Year Results Plus Sub-group Analysis —Stefan Müller-Hülsbeck, M.D.

8:59 AM — 2 Year Results of Paclitaxel Coated Balloons for Long Femoro-popliteal Artery Disease: Evidence from the SFA-Long Study — Antonio Micari, M.D., Ph.D.    

 

Presentations Wednesday, Sept. 21

9:10 AM — ESPRIT I Trial: Three-Year Results of The Evaluation of The ESPRIT Bioresorbable Vascular Scaffold (ESPRIT BVS) in The Treatment of Patients with Occlusive Vascular Disease of the Superficial Femoral (SFA) or Common or External Iliac Arteries — Richard Rapoza, M.D.  

9:22 AM — 12 Month Results from the DANCE Trial Atherectomy Cohort — Chris Owens, M.D.      

9:34 AM — Use of an Expanded Polytetrafluoroethylene (ePTFE) Balloon-Expandable Covered Stent for Obstructive Lesions in the Iliac Artery: Nine-Month Results from the Prospective, Multicenter BOLSTER Trial 
— John Laird, M.D.

9:44 AM — Carotid Stent Fractures are not associated with Restenosis, Stroke, Myocardial Infarction or Death: Results from the ACT 1 Multicenter Randomized Trial — Ido Weinberg, M.D.   

9:54 AM — Novel Nitinol Stent for Long Lesions in the Superficial Femoral Artery and Proximal Popliteal Artery: 24 Month Results from the TIGRIS Randomized Trial  — John Laird, M.D.   

10:04 AM — PRISM Indigo Aspiration System as a Potential Frontline Tool for Vacuum-assisted Aspiration Thrombectomy in the Periphery  — Richard Saxon, M.D. 

 

For more information: vivaphysicians.org/annual-conference/viva-16/

Related Content

Biotronik Studies Demonstrate Efficacy of Minimizing Metal Burden in SFA Therapy
News | Stents Bare Metal| September 22, 2017
Physicians demonstrated that reducing metal burden in superficial femoral artery (SFA) therapy could effectively reduce...
Tryton Side Branch Stent Recognized With Premier Technology Breakthrough Award
News | Stents Bifurcation| September 21, 2017
September 21, 2017 — Cardinal Health and Tryton Medical Inc.
Lesion Preparation Via Atherectomy Enhances Paclitaxel Distribution in Calcified Peripheral Arteries
News | Peripheral Artery Disease (PAD)| September 20, 2017
September 20, 2017 — Not-for-profit preclinical research institute CBSET announced that its scientists have published
DISRUPT BTK Study Shows Positive Results With Lithoplasty in Calcified Lesions Below the Knee
News | Peripheral Artery Disease (PAD)| September 20, 2017
Shockwave Medical reported positive results from the DISRUPT BTK Study, which were presented at the annual...
Corindus Announces First Patient Enrolled in PRECISION GRX Registry
News | Robotic Systems| September 18, 2017
September 18, 2017 — Corindus Vascular Robotics Inc.
Two-Year ILLUMENATE Trial Data Demonstrate Efficacy of Stellarex Drug-Coated Balloon
News | Drug-Eluting Balloons| September 18, 2017
Philips announced the two-year results from the ILLUMENATE European randomized clinical trial (EU RCT) demonstrating...
Sentinel Cerebral Protection System Significantly Reduces Stroke and Mortality in TAVR
News | Embolic Protection Devices| September 18, 2017
September 18, 2017 – Claret Medical announced publication of a new study in the...
Fysicon Receives FDA Approval for QMAPP Hemodynamic Monitoring System
Technology | Hemodynamic Monitoring Systems| September 18, 2017
Fysicon announced that it has been granted 510(k) clearance by the U.S. Food and Drug Administration (FDA) for its...
Peter Schneider, M.D. presents late breaking clinical trial results at VIVA 17 in Las Vegas. Panelists (l to r) Krishna Rocha-Singh, M.D., Sean Lyden, M.D., John Kaufman, M.D., Donna Buckley, M.D.

Peter Schneider, M.D. presents late breaking clinical trial results at VIVA 17 in Las Vegas. Panelists (l to r) Krishna Rocha-Singh, M.D., Sean Lyden, M.D., John Kaufman, M.D., Donna Buckley, M.D.

Feature | Cath Lab| September 14, 2017
September 14, 2017 — Here are quick summaries for all the key late-breaking vascular and endovascular clinical trials
Mississippi Surgical and Vascular Center Uses Toshiba Ultimax-i FPD to Save Patients' Limbs
News | Angiography| September 14, 2017
The southern U.S. sees some of the highest numbers of chronic medical conditions, such as peripheral artery disease...
Overlay Init